690264-82-5Relevant articles and documents
BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS
-
Page/Page column 20, (2009/07/17)
The invention provides novel bis-pyridylpyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy and for the treatment of obesity and/or diabetes.
Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonists
Dyck, Brian,Zhao, Liren,Tamiya, Junko,Pontillo, Joseph,Hudson, Sarah,Ching, Brett,Heise, Christopher E.,Wen, Jenny,Norton, Christi,Madan, Ajay,Schwarz, David,Wade, Warren,Goodfellow, Val S.
, p. 4237 - 4242 (2007/10/03)
A series of substituted chromones were designed, synthesized, and evaluated for their ability to bind melanin-concentrating hormone receptor 1. Compounds with subnanomolar binding affinity and 66% oral bioavailability in rats were discovered.
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
-
, (2008/06/13)
The present invention relates to alkyne compounds of general formula I wherein the groups and residues A, B, W, X, Y, Z, R1 and R2 have the meanings given in claim 1. The invention further relates to pharmaceutical compositions containing at least one alkyne according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.